Cromwell Holdings’s Novo Nordisk NVO Stock Holding History

Cromwell Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$314K	Buy	6,546 +2,150	+49%	+$92.4K	0.14%	125
2026 Q1	$167K	Sell	4,396 -1,436	-25%	-$68K	0.09%	214
2025 Q4	$297K	Sell	5,832 -50	-0.9%	-$2.56K	0.16%	120
2025 Q3	$326K	Sell	5,882 -1,258	-18%	-$73.6K	0.17%	111
2025 Q2	$493K	Buy	7,140 +1,436	+25%	+$97.7K	0.3%	60
2025 Q1	$396K	Sell	5,704 -1,204	-17%	-$99.4K	0.25%	83
2024 Q4	$594K	Buy	6,908 +766	+12%	+$82.8K	0.34%	44
2024 Q3	$731K	Hold	6,142	–	–	0.47%	31
2024 Q2	$877K	Buy	+6,142	New	+$814K	0.52%	28

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Cromwell Holdings's NVO Position: Q2 2026 in Review

Cromwell Holdings increased its Novo Nordisk (NVO) stake by 49% in Q2 2026, buying an estimated $92.4K and bringing the position to 6,546 shares worth $314K. The position accounts for 0.14% of the portfolio, ranked #125.

Cromwell Holdings first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $877K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Cromwell Holdings held 6,546 shares of Novo Nordisk worth $314K as of Q2 2026.
Cromwell Holdings bought 2,150 Novo Nordisk shares in Q2 2026, an estimated $92.4K.
Novo Nordisk made up 0.14% of Cromwell Holdings's portfolio in Q2 2026, its #125 holding.
Cromwell Holdings first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
Cromwell Holdings's Novo Nordisk position peaked at $877K in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.